Delivery Order SPE2DB22D1017-SPE2DB25FYSHZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $14,237.99. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract represents a single delivery order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a delivery order valued at $26,271.27 to AmerisourceBergen Drug Corp for the supply of Janumet 50-500 mg tablets (60-count packages). This competitive, non-set-aside firm fixed price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,345.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a non-set-aside award issued through competitive procurement. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count packages) under a firm fixed-price contract valued at $6,537.32. This is a competitive, non-set-aside award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $4,620.99 and a firm fixed price structure. The order was issued on September 10, 2025, with an ultimate completion date of September 11, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $28,069.24 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count packages). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.18 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. The contract falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 8, 2025, with a ceiling value of $6,644.43 and firm fixed pricing. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSHZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,086.48 to AmerisourceBergen Drug Corp for the supply of Janumet 50-500 mg tablets (180-count) on September 29, 2025. The order, which is classified as firm fixed price with no set-aside designation, represents a competitive procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls under the company's prime IDC valued at $999,999,999.00, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The performance location for this order is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its DLA contract portfolio. As a prime contractor under the DLA Troop Support Medical program, the company supplies a comprehensive range of pharmaceutical products, including brand-name and generic medications, across multiple therapeutic domains to support military and veteran healthcare systems. This specific delivery order for Janumet, a diabetes medication, exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for the Department of Defense healthcare infrastructure. All of AmerisourceBergen's reviewed federal contract awards have been competitively procured without set-asides, demonstrating the company's capability to meet stringent federal medical supply standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/29/25 |